The company identifies and develops new medications for people suffering from autoimmune disorders like lupus. Its lead drug candidate is moving into mid-stage testing to evaluate its effectiveness and safety. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
